Wang, X.; Weng, S. -Y.; Chen, T. et al.
Glucagon-like peptide-1 receptor agonists ameliorate inflammation and fibrosis in an optimized rodentNASH model via inhibition of inflammatory macrophage activationJOURNAL OF HEPATOLOGY. Bd. 66. H. 1. 2017 S. S610-S611
Steven, Sebastian; Jurk, Kerstin; Kopp, Maximilian et al.
Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic miceBRITISH JOURNAL OF PHARMACOLOGY. Bd. 174. H. 12. 2017 S. 1620-1632
Korschelt, Karsten; Ragg, Ruben; Metzger, Carmen S. et al.
Glycine-functionalized copper(II) hydroxide nanoparticles with high intrinsic superoxide dismutase activityNANOSCALE. Bd. 9. H. 11. 2017 S. 3952-3960
Kahaly, George J.; Olivo, Paul D.
Graves' DiseaseNEW ENGLAND JOURNAL OF MEDICINE. Bd. 376. H. 2. 2017 S. 184-184
Perros, P.; Hegedus, L.; Bartalena, L. et al.
Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statementORPHANET JOURNAL OF RARE DISEASES. Bd. 12. 2017
Dietz, Julia; Vermehren, Johannes; Susser, Simone et al.
HCV resistance-associated substitutions in patients with HCV genotype 4 and failure to DAA combination therapies and implications for a retreatmentHEPATOLOGY. Bd. 66. 2017 S. 572A-573A
Hammond, Edward R.; Friedel, Heiko; Garal-Pantaler, Elena et al.
Health Care Costs of Patients with Systemic Lupus Erythematosus (SLE) Versus Control Patients As a Function of Disease Severity: Analysis of the Betriebskrankenkassen German Sickness FundARTHRITIS & RHEUMATOLOGY. Bd. 69. 2017
Huber, Y.; Labenz, C.; Ganter, M. et al.
Health-related quality of life in patients with non-alcoholic fatty liver diseaseJOURNAL OF HEPATOLOGY. Bd. 66. H. 1. 2017 S. S597-S598
Gehrke, Nadine; Woerns, Marcus A.; Mann, Amrit et al.
Hepatic B cell leukemia-3 suppresses chemically-induced hepatocarcinogenesis in mice through altered MAPK and NF-kappa B activationONCOTARGET. Bd. 8. H. 34. 2017 S. 56095-56109
Nagel, Michael; Schwarting, Andreas; Straub, Beate K. et al.
Hepatic manifestation of a macrophage activation syndrome (MAS)ZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 55. H. 5. 2017 S. 473-478